Skip to main content

Published locations for Certolizumab may reduce uveitis flares, axSpA disease activity

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Certolizumab may reduce uveitis flares, axSpA disease activity

User login

  • Reset your password
  • /content/certolizumab-may-reduce-uveitis-flares-axspa-disease-activity
  • /internalmedicinenews/article/213733/ankylosing-spondylitis/certolizumab-may-reduce-uveitis-flares
  • /rheumatologynews/article/213733/ankylosing-spondylitis/certolizumab-may-reduce-uveitis-flares-axspa
  • /rheumatology/article/213733/ankylosing-spondylitis/certolizumab-may-reduce-uveitis-flares-axspa
  • /internalmedicine/article/213733/ankylosing-spondylitis/certolizumab-may-reduce-uveitis-flares-axspa